EG BioMed Earns CAP Accreditation, Boosting YD Bio's Cancer Diagnostics
EG BioMed is one of YD Bio’s key licensing partners for pancreatic and breast cancer detection and collaborates with 3D Global to develop treatments for eye disorders.
EG BioMed Earns CAP Accreditation | 13/10/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy